Proton therapy in pediatric neuro-oncology. Potential advantages and the relationship between cost and results

Author:

Regentova O. S.1ORCID,Shcherbenko O. I.1ORCID,Kumirova E. V.2ORCID,Antonenko F. F.1ORCID,Solodkiy V. A.1ORCID

Affiliation:

1. Russian Scientific Center of Roentgenoradiology of the Ministry of Health of Russia

2. Russian Scientific Center of Roentgenoradiology of The Ministry of Health of Russia; Morozov Children’s City Clinical Hospital of The Moscow City, Healthcare Department; N.N. Blokhin National Medical Research Center of Oncology of The Ministry of Health of The Russia; N.I. Pirogov Russian National Research Medical University of The Ministry of Health of Russia

Abstract

The aim of study: to analyze the accumulated experience and try to identify those clinical situations in which the use of protons will be economically and clinically more effective than photon radiation therapy. Material and methods. The articles devoted to the study of the evaluation and comparison of the effectiveness of proton and photon radiation beams in the treatment of tumors of the central nervous system and published over the past 25 years were searched in the Medline, Embase and the Cochrane Library databases. Results. the analysis of available publications has shown that accelerated protons do not improve survival rates and disease-free rates in all forms of brain tumors compared with photon therapy. However, protons can significantly increase the level of dose distribution conformity and reduce the dose to critical structures (pituitary gland, cochlea, eye lenses, hypothalamus), thus reducing the risk of hearing and visual impairment as well as hormonal and cognitive disorders. All this is critically important for potentially curable malignant tumors, such as medulloblastoma and germinoma, for low malignant potential tumors (grade 1–2 glioma) or tumors with decreased metastatic potential, since proton therapy compared to photon therapy reduces the risk of late side effects that worsen the quality of life of cured children. Conclusion. central nervous system tumors are one of the most common solid malignant neoplasms in children. Radiation therapy (RT) is recognized as an important therapeutic component of treatment and is often used in strategies for multimodal therapy of tumors of the central nervous system in children. Proton radiation therapy is one of the attractive methods of radiotherapy with minimal dose distribution to normal tissues and a decrease in the absorbed dose. The precision of protons reduces the risk of long-term side effects associated with this type of treatment and the induction of secondary malignancies, which is of particular importance for the quality of life.

Publisher

Tomsk Cancer Research Institute

Reference44 articles.

1. Malignant tumors in Russia in 2020 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow, 2021. 239 p. (in Russian).

2. Geyer J.R., Sposto R., Jennings M., Boyett J.M., Axtell R.A., Breiger D., Broxson E., Donahue B., Finlay J.L., Goldwein J.W., Heier L.A., Johnson D., Mazewski C., Miller D.C., Packer R., Puccetti D., Radcliffe J., Tao M.L., Shiminski-Maher T. Children’s Cancer Group. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. J Clin Oncol. 2005; 23(30): 7621–31. doi: 10.1200/JCO.2005.09.095.

3. Oeffinger K.C., Mertens A.C., Sklar C.A., Kawashima T., Hudson M.M., Meadows A.T., Friedman D.L., Marina N., Hobbie W., Kadan-Lottick N.S., Schwartz C.L., Leisenring W., Robison L.L.; Childhood Cancer Survivor Study. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006; 355(15): 1572–82. doi: 10.1056/NEJMsa060185.

4. Armstrong G.T., Liu Q., Yasui Y., Neglia J.P., Leisenring W., Robison L.L., Mertens A.C. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009; 27(14): 2328–38. doi: 10.1200/JCO.2008.21.1425.

5. Paganetti H., Niemierko A., Ancukiewicz M., Gerweck L.E., Goitein M., Loeffler J.S., Suit H.D. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002; 53(2):407–21. doi: 10.1016/s0360-3016(02)02754-2.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3